Show simple item record

dc.contributor.authorAlvarado-García, Paul Alan Arkin
dc.contributor.authorSoto-Vásquez, Marilú Roxana
dc.contributor.authorInfantes Gomez, Francisco Mercedes
dc.contributor.authorRodríguez de Guzmán, Yolanda Elizabeth
dc.contributor.authorCubas Romero, Taniht Lisseth
dc.contributor.authorGuzmán Rodríguez, Natalia Mavila
dc.contributor.authorRodríguez Aguilar, Olga Gessy
dc.contributor.authorHonores Alvarado, Ana María
dc.contributor.authorVargas Díaz, Elsa Rocío
dc.contributor.authorCabrera Cabrera, Lesly Alexandra
dc.contributor.authorTruyenque Román, Klersy Almendra
dc.contributor.authorBriceño Esquivel, Edwar Guido
dc.date.accessioned2023-09-08T17:27:21Z
dc.date.available2023-09-08T17:27:21Z
dc.date.issued2022
dc.identifier.urihttps://hdl.handle.net/20.500.13067/2567
dc.description.abstractIntroduction: The aim of this research was to evaluate the effects of Satureja brevicalyx essential oil inhalation on premenstrual syndrome. Methods: The oils were extracted by hydro-distillation using a modified Clevenger-type apparatus and chemical composition was performed by Gas chromatography-mass spectrometry (GC–MS). Furthermore, a quasi-experimental study was conducted, where 61 participants were divided in two groups, comprising an experimental with essential oils and a control group with no treatment. Main psychological symptoms were assessed with the used of Zung Self-Rating Anxiety Scale (SAS) and Zung Self-Rating Depression Scale (SDS) as well as total score of premenstrual syndrome was evaluated with Premenstrual Syndrome Scale (PMSS). Results: chemical analysis showed that linalool (17.6%) was the main component. All variables showed a decrease in posttest study phase in comparison with pretest in experimental group (p <0.05). A large size effect was observed for anxiety (d = 1.25; Δ = 1.35). Besides, moderate changes were found for depression (d = 0.79; Δ = 0.81) and premenstrual syndrome total score (d = 0.62; Δ = 0.56). Conclusion: The essential oil of Satureja brevicalyx exerts a potencial use, especially for the treatment of psychological symptoms of premenstrual syndrome.es_PE
dc.formatapplication/pdfes_PE
dc.language.isoenges_PE
dc.publisherPharmacogn J.es_PE
dc.rightsinfo:eu-repo/semantics/openAccesses_PE
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/es_PE
dc.subjectEssential oilses_PE
dc.subjectPremenstrual syndromees_PE
dc.subjectAnxietyes_PE
dc.subjectDepressiones_PE
dc.subjectSatureja brevicalyxes_PE
dc.titleEffects of Satureja brevicalyx essential oil inhalation on coping premenstrual syndromees_PE
dc.typeinfo:eu-repo/semantics/articlees_PE
dc.identifier.journalPharmacognosy Journales_PE
dc.identifier.doihttps://doi.org/10.5530/pj.2022.14.160
dc.subject.ocdehttps://purl.org/pe-repo/ocde/ford#5.01.00es_PE
dc.relation.urlhttps://phcogj.com/article/1903es_PE
dc.source.volume4es_PE
dc.source.issue16es_PE
dc.source.beginpage728es_PE
dc.source.endpage735es_PE


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

info:eu-repo/semantics/openAccess
Except where otherwise noted, this item's license is described as info:eu-repo/semantics/openAccess